BioCorRx Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

BioCorRx Inc. reported Cash And Cash Equivalents At Carrying Value of $592.1 thousand for the year ending 2020.

  • BioCorRx Inc. showed a decrease of -77.6% in Cash And Cash Equivalents At Carrying Value from 2019 to 2020.
  • This data is from BioCorRx Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2022.
  • XBRL data for this metric is available from 2009 to 2020 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 10 years of available data (2009 to 2020), BioCorRx Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 2,020.6%.
  • Historical annual values: Fiscal year 2020: $592.1 thousand | Fiscal year 2019: $2.65 million | Fiscal year 2018: $279.8 thousand | Fiscal year 2015: $220.1 thousand | Fiscal year 2014: $53.1 thousand | Fiscal year 2013: $108.6 thousand | Fiscal year 2012: $6.0 thousand | Fiscal year 2011: $1.7 thousand | Fiscal year 2010: $7.1 thousand | Fiscal year 2009: $27.9 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: